Search database
LIST OPTIONS
Filter
64
Filtered Results: 64
Text search: вирусом
Featured
Language
Document type
Guidelines
31
No document type
16
Fact sheets
4
Manuals
3
Infographics
3
Studies & Reports
2
Online Courses
2
Brochures
1
Resource Platforms
1
Strategic & Response Plan
1
Countries / Regions
Russia
25
Eastern Europe
5
Eastern Europe and Central Asia
4
Global
3
Africa
3
Latin America and the Carribbean
3
East and Southern Africa
3
Sierra Leone
2
Liberia
2
Ukraine
1
Ghana
1
Nigeria
1
Mozambique
1
Germany
1
West and Central Africa
1
Angola
1
Authors & Publishers
World Health Organization WHO
23
World Health Organization
8
Всемирная организация здравоохранения (ВОЗ)
5
Всемирная организация здравоохранения (Eвропейское)
4
Pan American Health Organisation PAHO
3
Regional Office for Africa
3
UNESCO
3
UNESCO Institute for Information Technologies in Education , Joint United Nations Programme on HIV
3
UNAIDS
2
UNITAID
2
WHO
2
Всемирная организация здравоохранения
2
A.Hill, T. Swan and K.Timmermans
1
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
Bernard M. Branson, S. Michele Owen, Laura G. Wesolowski et
1
Bundesinstitut für Arzneimittel und Medizinprodukte
1
Centers for Disease control and Prevention
1
Cheesbrough, M.
1
Francis Aboagye-Nyame, Heather Alexander, Zelalem Gizachew Belachew et al.
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud OMS
1
Organización Panamericana de la Salud
1
Pan American Health Organization PAHO
1
THT Books
1
UNICEF
1
UNITAID Secretariat, World Health Organization
1
WHO, THE END TB STRATEGY
1
World Health Organisation (WHO)
1
World Health Organization (WHO)
1
World Health Organization, Regional Office for the Americas
1
ВОЗ
1
Министерство здравоохранения Российской Федерации
1
Московский городской научно- практический центр борьбы с туберкулёзом Департамента здравоохранения города Москвы
1
Мохрякова Т. Е., Синицын М. В
1
С. Н. Авдеев , Е. В. Волчкова , О. М. Драпкина, et al.
1
Publication Years
Category
Virology
29
COVID-19
27
Hepatitis
6
Online Courses & Platforms
2
Bacteriology
1
General Guidelines
1
MPOX - Monkeypox
1
Yellow Fever
1
Policies
1
Capacity Building
1
Parasitology
1
Laboratory Technologies
1
HIV & STI
1
Disease Prevention & Control
1
Toolboxes
Diagnostics & Laboratory Guidance
19
Country specific documents
12
Laboratory Guidance
5
Infection Control General
4
For General Public & Community
4
For Health Worker
4
Genomic sequencing
4
Laboratory & Sampling
2
Clinical Guidelines
2
Online Courses & Resources
2
PPE Personel Protective Equipment
2
Poster & Infographics
2
Surveillance & Contact tracing
2
For Parents & Children
2
HIV and COVID-19
2
Coping with Stress
2
Zika
2
Laboratory & Diagnostics
2
Drugs
1
Rapid Response
1
TB & Drug Abuse
1
HIV testing & services
1
Clinical Aspects, Treatment & Prevention
1
Yellow Fever
1
Yellow Fever Prevention & Control
1
Adults
1
Public Health
1
Laboratory
1
Laboratory
1
Laboratory
1
Prevention & Preparedness
1
Context & Facts, Travel Advice
1
Clinical Aspects
1
Public Health
1
Hand Hygiene
1
Human Rights
1
Guidelines
1
Scientific & Research Studies
1
Educational Settings
1
Medical & Community Masks
1
Infection Control & Prevention (IPC)
1
General
1
Stigmatisation
1
Hospital Readiness/Essential Health Services
1
Mythbusters/Misinformation
1
SARS-CoV-2 Variants
1
MPOX - Monkeypox
1
Access to treatment and laboratory
1
Drug resistant TB
1
Substance Use Disorders & Addiction
1
General Public
1
TB/HIV Coinfection
1
Laboratory
1
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China. 19 March 2020
July 2018 This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United... more
July 2016
This algorithm is addressed to laboratories with established capacity(molecular, antigenic and/orserological) to detect dengue (DENV), Zika (ZIKV), and chikungunya(CHIKV) as part of the differential diagnosis for arborviruses. A BSL2 containment level is required to handle suspected samples.
Este algoritmo está dirigido a aquellos laboratorios que cuentan con capacidad instalada para la detección (molecular, antigénica y/o serológica) de dengue (DENV), Zika (ZIKV) y chikungunya(CHIKV),y como parte del diagnóstico diferencial para Arbovirus. Para la manipulación de muestras sosp... more
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV).
Semi-annual Update
Second Edition AIDS Medicines and diagnostics services July 2015
This document updates recommendations for HIV testing by laboratories in the United States and offers approaches for reporting test results to persons ordering HIV tests and to public health authorities. The recommended algorithm is a sequence of tests used in combination to improve the accuracy of ... more
Interim Recommendation published 19 September 2014. These recommendations reflect current understanding of Ebola virus disease (EVD) and are intended for national laboratory staff performing diagnostic testing to detect Ebola virus.
15 May 2022
To meet the need for laboratory diagnosis to be integrated in community care, the new 2022 Update describes point-of-care tests that can be performed both in district laboratories and peripheral healthcare facilities by non-specialist staff. Also included are recently developed self-tests.
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta... more
Tests zur Detektion einer Infektion mit SARS-CoV-2 (neuartiges Coronavirus) sowie zum Nachweis von Antikörpern gehören zu den sog. In-vitro-Diagnostika (IVD). Das erstmalige Inverkehrbringen von In-vitro-Diagnostika auf dem deutschen Markt ist nach §§ 25 und 30 Medizinproduktegesetz (MPG) anzeig... more
8 July 2020
8 jul 2020